GlycoMimetics Inc - Company Profile
Powered by 
All the data and insights you need on GlycoMimetics Inc in one report.
$295
- Save hours of research time and resources with
our up-to-date GlycoMimetics Inc Strategy Report
- Understand GlycoMimetics Inc position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
The following section provides information on GlycoMimetics Inc’s senior management, executives, CEO and key decision makers and their roles in the organization. For more insight into GlycoMimetics Inc's management and employees, unlock the full data with our company analytics monitoring tool.
Executives
Timothy R. Pearson
Chairman Executive BoardMr. Timothy R. Pearson has been the Chairman of the company since 2019. He also serves as a Member of the Board of Ra Pharmaceuticals Inc. Prior to this, he served as the Chief Executive Officer of Carrack Therapeutics. Previously, he served as the Executive Vice President and Chief Financial Officer for TESARO Inc from May 2014 until its acquisition by GlaxoSmithKline in February 2019. Mr. Pearson also served as the Executive Vice President, Chief Financial Officer and Treasurer of Catalyst Health Solutions from August 2011 until its acquisition by SXC Health Solutions in July 2012. Prior to joining Catalyst Health Solutions, he served as the Chief Financial Officer and the Executive Vice President of MedImmune.
Harout Semerjian
Chief Executive Officer; President Senior ManagementMr. Harout Semerjian has been the Chief Executive Officer and President of the company since 2021. Prior to this, he served as the President and Chief Executive Officer at Immunomedics Inc. Mr. Semerjian has also served as the Executive Vice President and Chief Commercial Officer at Ipsen Pharma.
Brian Hahn
Chief Financial Officer; Senior Vice President Senior ManagementMr. Brian Hahn has been the Chief Financial Officer and Senior Vice President of the company since 2019. Prior to this, he served as the Chief Executive Officer and he also served as Director of Finance and Administration from 2010 to 2012. Mr. Hahn also served as an Assistant Controller for OpGen Inc. Prior to joining OpGen, he served as the Executive Director of Finance at MiddleBrook Pharmaceuticals.
Edwin Rock, M.D
Chief Medical Officer; Senior Vice President Senior ManagementMr. Edwin Rock, M.D has been the Chief Medical Officer and Senior Vice President of the company since 2022. Prior to this, he served as the Chief Medical Officer at Partner Therapeutics. Mr. Edwin also served as the Vice President of Clinical Development of MacroGenics Inc.
Bruce Johnson
Chief Commercial Officer; Senior Vice President Senior ManagementMr. Bruce Johnson has been the Senior Vice President and Chief Commercial Officer of the company since 2022. Prior to this, he served as the Executive Vice President and Chief Commercial Officer of Cancer Expert Now, Inc. Mr. Johnson also served as the Vice President, Global Commercial Development, Oncology at AbbVie.
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer